Skip to content

Factor V Short Isoforms Related Bleeding Disorder C5680279

Published: July 22, 2026Updated: August 20, 2026

A rare bleeding disorder involving abnormal short forms of Factor V protein that do not function properly. It affects both males and females. Treatment focuses on replacing clotting factors during active bleeding.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Prolonged bleeding after dental extraction

(hematologic)

Gum bleeding

(hematologic)

Petechiae

(hematologic)

Deep muscle hematoma

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Fresh Frozen Plasma Therapy

Replacement therapy for factor V short isoform deficiency providing functional factor V to support adequate hemostasis during bleeding events or procedures.

medication
3

Desmopressin Trial and Response Assessment

Controlled DDAVP administration to assess individual response, as some patients with short isoform variants may have variable factor VIII elevations.

medication

Additional treatment options

Tranexamic Acid Prophylaxis

Regular antifibrinolytic therapy for patients with recurrent bleeding from factor V short isoform dysfunction affecting clot stability.

medication

Trauma Prevention and Activity Counseling

Comprehensive lifestyle guidance emphasizing avoidance of contact sports and high-impact activities while maintaining safe physical fitness alternatives.

lifestyle

Specialized Coagulation Testing

Periodic specialized testing for factor V isoform analysis and functional assays to characterize bleeding phenotype and guide treatment intensity.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Factor V Short Isoforms Related Bleeding Disorder C5680279?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Factor V Short Isoforms Related Bleeding Disorder C5680279. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy